Legend for Supplementary Figure 1 from IFNγ-Dependent Interactions between ICAM-1 and LFA-1 Counteract Prostaglandin E2–Mediated Inhibition of Antitumor CTL Responses Article Swipe
Fatemah Basingab
,
Maryam Ahmadi
,
David J. Morgan
·
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1158/2326-6066.22537640.v1
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1158/2326-6066.22537640.v1
Legend for Supplementary Figure 1
Related Topics
Concepts
Metadata
- Type
- preprint
- Language
- en
- Landing Page
- http://doi.org/10.1158/2326-6066.22537640.v1
- OA Status
- gold
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4362539766
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4362539766Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1158/2326-6066.22537640.v1Digital Object Identifier
- Title
-
Legend for Supplementary Figure 1 from IFNγ-Dependent Interactions between ICAM-1 and LFA-1 Counteract Prostaglandin E2–Mediated Inhibition of Antitumor CTL ResponsesWork title
- Type
-
preprintOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2023Year of publication
- Publication date
-
2023-04-03Full publication date if available
- Authors
-
Fatemah Basingab, Maryam Ahmadi, David J. MorganList of authors in order
- Landing page
-
https://doi.org/10.1158/2326-6066.22537640.v1Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.1158/2326-6066.22537640.v1Direct OA link when available
- Concepts
-
Legend, Prostaglandin E2, CTL*, ICAM-1, Prostaglandin, Medicine, Art, Internal medicine, Biology, Intracellular, Cell biology, Immunology, Art history, Immune system, CD8Top concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4362539766 |
|---|---|
| doi | https://doi.org/10.1158/2326-6066.22537640.v1 |
| ids.doi | https://doi.org/10.1158/2326-6066.22537640.v1 |
| ids.openalex | https://openalex.org/W4362539766 |
| fwci | 0.0 |
| type | preprint |
| title | Legend for Supplementary Figure 1 from IFNγ-Dependent Interactions between ICAM-1 and LFA-1 Counteract Prostaglandin E2–Mediated Inhibition of Antitumor CTL Responses |
| biblio.issue | |
| biblio.volume | |
| biblio.last_page | |
| biblio.first_page | |
| topics[0].id | https://openalex.org/T10678 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9968000054359436 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2736 |
| topics[0].subfield.display_name | Pharmacology |
| topics[0].display_name | Inflammatory mediators and NSAID effects |
| topics[1].id | https://openalex.org/T10831 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.987500011920929 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2723 |
| topics[1].subfield.display_name | Immunology and Allergy |
| topics[1].display_name | Cell Adhesion Molecules Research |
| topics[2].id | https://openalex.org/T12505 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.980400025844574 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2730 |
| topics[2].subfield.display_name | Oncology |
| topics[2].display_name | Peptidase Inhibition and Analysis |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C2776142151 |
| concepts[0].level | 2 |
| concepts[0].score | 0.8852652311325073 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q44342 |
| concepts[0].display_name | Legend |
| concepts[1].id | https://openalex.org/C2777956040 |
| concepts[1].level | 2 |
| concepts[1].score | 0.5988073945045471 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q416554 |
| concepts[1].display_name | Prostaglandin E2 |
| concepts[2].id | https://openalex.org/C147969180 |
| concepts[2].level | 4 |
| concepts[2].score | 0.5897078514099121 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q5014579 |
| concepts[2].display_name | CTL* |
| concepts[3].id | https://openalex.org/C185946421 |
| concepts[3].level | 3 |
| concepts[3].score | 0.43679213523864746 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q3146527 |
| concepts[3].display_name | ICAM-1 |
| concepts[4].id | https://openalex.org/C2780664492 |
| concepts[4].level | 2 |
| concepts[4].score | 0.42941814661026 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q209717 |
| concepts[4].display_name | Prostaglandin |
| concepts[5].id | https://openalex.org/C71924100 |
| concepts[5].level | 0 |
| concepts[5].score | 0.3304629921913147 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[5].display_name | Medicine |
| concepts[6].id | https://openalex.org/C142362112 |
| concepts[6].level | 0 |
| concepts[6].score | 0.2839306890964508 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q735 |
| concepts[6].display_name | Art |
| concepts[7].id | https://openalex.org/C126322002 |
| concepts[7].level | 1 |
| concepts[7].score | 0.2693396806716919 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[7].display_name | Internal medicine |
| concepts[8].id | https://openalex.org/C86803240 |
| concepts[8].level | 0 |
| concepts[8].score | 0.2534143924713135 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[8].display_name | Biology |
| concepts[9].id | https://openalex.org/C79879829 |
| concepts[9].level | 2 |
| concepts[9].score | 0.22723513841629028 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q5571762 |
| concepts[9].display_name | Intracellular |
| concepts[10].id | https://openalex.org/C95444343 |
| concepts[10].level | 1 |
| concepts[10].score | 0.21814271807670593 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q7141 |
| concepts[10].display_name | Cell biology |
| concepts[11].id | https://openalex.org/C203014093 |
| concepts[11].level | 1 |
| concepts[11].score | 0.1920388638973236 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q101929 |
| concepts[11].display_name | Immunology |
| concepts[12].id | https://openalex.org/C52119013 |
| concepts[12].level | 1 |
| concepts[12].score | 0.17075103521347046 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q50637 |
| concepts[12].display_name | Art history |
| concepts[13].id | https://openalex.org/C8891405 |
| concepts[13].level | 2 |
| concepts[13].score | 0.11859637498855591 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q1059 |
| concepts[13].display_name | Immune system |
| concepts[14].id | https://openalex.org/C167672396 |
| concepts[14].level | 3 |
| concepts[14].score | 0.0 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q417800 |
| concepts[14].display_name | CD8 |
| keywords[0].id | https://openalex.org/keywords/legend |
| keywords[0].score | 0.8852652311325073 |
| keywords[0].display_name | Legend |
| keywords[1].id | https://openalex.org/keywords/prostaglandin-e2 |
| keywords[1].score | 0.5988073945045471 |
| keywords[1].display_name | Prostaglandin E2 |
| keywords[2].id | https://openalex.org/keywords/ctl* |
| keywords[2].score | 0.5897078514099121 |
| keywords[2].display_name | CTL* |
| keywords[3].id | https://openalex.org/keywords/icam-1 |
| keywords[3].score | 0.43679213523864746 |
| keywords[3].display_name | ICAM-1 |
| keywords[4].id | https://openalex.org/keywords/prostaglandin |
| keywords[4].score | 0.42941814661026 |
| keywords[4].display_name | Prostaglandin |
| keywords[5].id | https://openalex.org/keywords/medicine |
| keywords[5].score | 0.3304629921913147 |
| keywords[5].display_name | Medicine |
| keywords[6].id | https://openalex.org/keywords/art |
| keywords[6].score | 0.2839306890964508 |
| keywords[6].display_name | Art |
| keywords[7].id | https://openalex.org/keywords/internal-medicine |
| keywords[7].score | 0.2693396806716919 |
| keywords[7].display_name | Internal medicine |
| keywords[8].id | https://openalex.org/keywords/biology |
| keywords[8].score | 0.2534143924713135 |
| keywords[8].display_name | Biology |
| keywords[9].id | https://openalex.org/keywords/intracellular |
| keywords[9].score | 0.22723513841629028 |
| keywords[9].display_name | Intracellular |
| keywords[10].id | https://openalex.org/keywords/cell-biology |
| keywords[10].score | 0.21814271807670593 |
| keywords[10].display_name | Cell biology |
| keywords[11].id | https://openalex.org/keywords/immunology |
| keywords[11].score | 0.1920388638973236 |
| keywords[11].display_name | Immunology |
| keywords[12].id | https://openalex.org/keywords/art-history |
| keywords[12].score | 0.17075103521347046 |
| keywords[12].display_name | Art history |
| keywords[13].id | https://openalex.org/keywords/immune-system |
| keywords[13].score | 0.11859637498855591 |
| keywords[13].display_name | Immune system |
| language | en |
| locations[0].id | doi:10.1158/2326-6066.22537640.v1 |
| locations[0].is_oa | True |
| locations[0].source | |
| locations[0].license | cc-by |
| locations[0].pdf_url | |
| locations[0].version | acceptedVersion |
| locations[0].raw_type | posted-content |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | False |
| locations[0].raw_source_name | |
| locations[0].landing_page_url | http://doi.org/10.1158/2326-6066.22537640.v1 |
| locations[1].id | pmh:oai:figshare.com:article/22537640 |
| locations[1].is_oa | True |
| locations[1].source.id | https://openalex.org/S4306400572 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | OPAL (Open@LaTrobe) (La Trobe University) |
| locations[1].source.host_organization | https://openalex.org/I196829312 |
| locations[1].source.host_organization_name | La Trobe University |
| locations[1].source.host_organization_lineage | https://openalex.org/I196829312 |
| locations[1].license | cc-by |
| locations[1].pdf_url | |
| locations[1].version | submittedVersion |
| locations[1].raw_type | Text |
| locations[1].license_id | https://openalex.org/licenses/cc-by |
| locations[1].is_accepted | False |
| locations[1].is_published | False |
| locations[1].raw_source_name | |
| locations[1].landing_page_url | https://figshare.com/articles/journal_contribution/Legend_for_Supplementary_Figure_1_from_IFN_-Dependent_Interactions_between_ICAM-1_and_LFA-1_Counteract_Prostaglandin_E2_Mediated_Inhibition_of_Antitumor_CTL_Responses/22537640 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5084831700 |
| authorships[0].author.orcid | https://orcid.org/0000-0001-5251-559X |
| authorships[0].author.display_name | Fatemah Basingab |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Fatemah Salem Basingab |
| authorships[0].is_corresponding | False |
| authorships[1].author.id | https://openalex.org/A5072846893 |
| authorships[1].author.orcid | https://orcid.org/0000-0003-0765-9556 |
| authorships[1].author.display_name | Maryam Ahmadi |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Maryam Ahmadi |
| authorships[1].is_corresponding | False |
| authorships[2].author.id | https://openalex.org/A5103006294 |
| authorships[2].author.orcid | https://orcid.org/0000-0001-9896-0437 |
| authorships[2].author.display_name | David J. Morgan |
| authorships[2].author_position | last |
| authorships[2].raw_author_name | David John Morgan |
| authorships[2].is_corresponding | False |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | http://doi.org/10.1158/2326-6066.22537640.v1 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Legend for Supplementary Figure 1 from IFNγ-Dependent Interactions between ICAM-1 and LFA-1 Counteract Prostaglandin E2–Mediated Inhibition of Antitumor CTL Responses |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10678 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9968000054359436 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2736 |
| primary_topic.subfield.display_name | Pharmacology |
| primary_topic.display_name | Inflammatory mediators and NSAID effects |
| related_works | https://openalex.org/W2009676263, https://openalex.org/W2042894265, https://openalex.org/W1810219105, https://openalex.org/W2000524970, https://openalex.org/W2073561509, https://openalex.org/W2020599283, https://openalex.org/W2070238194, https://openalex.org/W2143424242, https://openalex.org/W2065944383, https://openalex.org/W1710496838 |
| cited_by_count | 0 |
| locations_count | 2 |
| best_oa_location.id | doi:10.1158/2326-6066.22537640.v1 |
| best_oa_location.is_oa | True |
| best_oa_location.source | |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | |
| best_oa_location.version | acceptedVersion |
| best_oa_location.raw_type | posted-content |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | |
| best_oa_location.landing_page_url | http://doi.org/10.1158/2326-6066.22537640.v1 |
| primary_location.id | doi:10.1158/2326-6066.22537640.v1 |
| primary_location.is_oa | True |
| primary_location.source | |
| primary_location.license | cc-by |
| primary_location.pdf_url | |
| primary_location.version | acceptedVersion |
| primary_location.raw_type | posted-content |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | False |
| primary_location.raw_source_name | |
| primary_location.landing_page_url | http://doi.org/10.1158/2326-6066.22537640.v1 |
| publication_date | 2023-04-03 |
| publication_year | 2023 |
| referenced_works_count | 0 |
| abstract_inverted_index.for | 1 |
| abstract_inverted_index.Figure | 3 |
| abstract_inverted_index.1</p> | 4 |
| abstract_inverted_index.Supplementary | 2 |
| abstract_inverted_index.<p>Legend | 0 |
| cited_by_percentile_year | |
| countries_distinct_count | 0 |
| institutions_distinct_count | 3 |
| citation_normalized_percentile.value | 0.06183859 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |